A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I

Journal of Clinical Investigation

Volumn 111, Issue 1, 2003, Pages 99-107

  Wang, Nan ^a   Chen, Wengen ^a   Linsel Nitschke, Patrick ^a   Martinez, Laurent O ^a   Agerholm Larsen, Birgit ^a   Silver, David L ^a   Tall, Alan R ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; APOLIPOPROTEIN A1; CALPAIN; CHOLESTEROL; PEPTIDE DERIVATIVE; PHOSPHOLIPID; PROLYLGLUTAMYLSERYLTHREONINE; PROTEINASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; EFFUSION; FOAM CELL; IN VIVO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN STABILITY; REGULATORY MECHANISM; TANGIER DISEASE;

AMINO ACID SEQUENCE; ANIMALS; APOLIPOPROTEIN A-I; ARTERIOSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CALPAIN; CELL LINE; CELL MEMBRANE; CELLS, CULTURED; CHICKENS; CHOLESTEROL; CROSS-LINKING REAGENTS; DIPEPTIDES; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOPEPTIDASES; GLUTAMIC ACID; HEPATOCYTES; HUMANS; LIGANDS; LIPID METABOLISM; MACROPHAGES; MICE; MOLECULAR SEQUENCE DATA; PHOSPHOLIPIDS; PLASMIDS; PROLINE; SERINE; THREONINE; TIME FACTORS; TRANSFECTION; UP-REGULATION;

EID: 0037253264     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200316808     Document Type: Article

References (43)

1. Brown, M.S., Ho, Y.K., and Goldstein, J.L. 1980. The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and re-esterification of cytoplasmic cholesteryl esters. J. Biol. Chem. 255:9344-9352.
2. Ho, Y.K., Brown, M.S., and Goldstein, J.L. 1980. Hydrolysis and excretion of cytoplasmic cholesreryl esters by macrophages: stimulation by high density lipoprotein and other agents. J. Lipid Res. 21:391-398.
3. Oram, J.F., Albers, J.J., Cheung, M.C., and Bierman, E.L. 1981. The effects of subfractions of high density lipoprotein on cholesterol efflux from cultured fibroblasts. Regulation of low density lipoprotein receptor activity. J. Biol. Chem. 256:8348-8356.
4. Rubin, E.M., Krauss, R.M., Spangler, E.A., Verstuyft, J.G., and Clift, S.M. 1991. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature. 353:265-267.
5. Plump, A.S., Scott, C.J., and Breslow, J.L. 1994. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA. 91:9607-9611.
6. Chiesa, G., et al. 2002. Recombinant apolipoprotein A-I(Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaks. Circ. Res. 90:974-980.
7. Eriksson, M., Carlson, L.A., Miettinen, T.A., and Angelin, B. 1999. Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans. Circulation. 100:594-598.
8. Cole, T.G., Nowatzke, W.L., Bisgaier, C.L., and Krause, B.R. 2002. Method-dependent changes in "HDL-cholesterol" with recombinant apolipoprotein A-I(Milano) infusion in healthy volunteers. Clin. Chem. 48:680-681.
9. Lusis, A.J. 2000. Atherosclerosis. Nature. 407:233-241.
10. Tall, A.R., and Wang, N. 2000. Tangier disease as a test of the reverse cholesterol transport hypothesis. J. Clin. Invest. 106:1205-1207.
11. Schaefer, E.J., Zech, L.A., Schwartz, D.E., and Brewer, H.B., Jr. 1980. Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease). Ann. Intern. Med. 93:261-266.
12. Brooks-Wilson, A., et al. 1999. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22:336-345.
13. Attie, A.D., Kastelein, J.P., and Hayden, M.R. 2001. Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis. J. Lipid Res. 42:1717-1726.
14. Wang, N., Silver, D.L., Coster, P., and Tall, A. R. 2000. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J. Biol. Chem. 275:33053-33058.
15. Repa, J.J., et al. 2000. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science. 289:1524-1529.
16. Coster, P., Luo, Y., Wang, N., and Tall, A.R. 2000. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J. Biol. Chem. 275:28240-28245.
17. Langmann, T., et al. 1999. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem. Biophys. Res. Commun. 257:29-33.
18. Oram, J.F., Lawn, R.M., Garvin, M.R., and Wade, D.P. 2000. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J. Biol. Chem. 275:34508-34511.
19. Arakawa, R., and Yokoyama, S. 2002. Helical apolipoproteins stabilize ATP-binding cassette transporter Al by protecting it from thiol protease-mediated degradation. J. Biol. Chem. 277:22426-22429.
20. Honkakoski, P., and Negishi, M. 1998. Protein serine/threonine phosphatase inhibitors suppress phenobarbital-induced Cyp2b 10 gene transcription in mouse primary hepatocytes. Biochem. J. 330:889-895.
21. Rechsteiner, M., and Rogers, S.W. 1996. PEST sequences and regulation by proteolysis. Trends Biochem. Sci. 21:267-271.
22. WWW PESTfind Analysis. European Molecular Biology Network. http://at.embnet.org/embnet/tools/bio/PESTfind/.
23. Roth, A.F., Sullivan, D.M., and Davis, N.G. 1998. A large PEST-like sequence directs the ubiquitination, endocytosis, and vacuolar degradation of the yeast a-factor receptor. J. Cell Biol. 142:949-961.
24. Shumway, S.D., Maki, M., and Miyamoto, S. 1999. The PEST domain of IkappaBalpha is necessary and sufficient for in vitro degradation by mucalpain. J. Biol. Chem. 274:30874-30881.
25. Tsujinaka, T., et al. 1988. Synthesis of a new cell penetrating calpain inhibitor (calpeptin). Biochem. Biophys. Res. Commun. 153:1201-1208.
26. Nanjee, M.N., Cooke, C.J., Olszewski, W.L., and Miller, N.E. 2000. Concentrations of electrophoretic and size subclasses of apolipoprotein AI-containing particles in human peripheral lymph. Arterioscler. Thromb. Vasc. Biol. 20:2148-2155.
27. Chen, W., et al. 2001. Preferential ATP-binding cassette transporter A1mediated cholesterol efflux from late endosomes/lysosomes. J. Biol. Chem. 276:43564-43569.
28. Wang, N., Silver, D.L., Thiele, C., and Tall, A.R. 2001. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J. Biol. Chem. 276:23742-23747.
29. Marguet, D., Luciani, M.F., Moynault, A., Williamson, P., and Chimini, G. 1999. Engulfment of apoptotic cells involves the redistribution of membrane phosphatidylserine on phagocyte and prey. Nat. Cell Biol. 1:454-456.
30. Fitzgerald, M.L., et al. 2002. Naturally occurring mutations in ABCA1's largest extracellular loops can disrupt its direct interaction with apolipoprotein A-I. J. Biol. Chem. 277:33178-33187.
31. Remaley, A.T., et al. 2001. Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem. Biophys Res. Commun. 280:818-823.
32. Mahley, R.W., et al. 1989. Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits. J. Clin. Invest. 83:2125-2130.
33. Bellosta, S., et al. 1995. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J Clin. Invest. 96:2170-2179.
34. Imajoh, S., Kawasaki, H., and Suzuki, K. 1986. The amino-terminal hydrophobic region of the small subunit of calcium-activated neutral protease (CANP) is essential for its activation by phosphatidylinositol. J. Biochem. (Tokyo). 99:1281-1284.
35. Sorimachi, H., and Suzuki, K. 2001. The structure of calpain. J. Biochem. (Tokyo). 129:653-664.
36. Suzuki, K. 1991. Nomenclature of calcium dependent proteinase. Biomed. Biochim. Acta. 50:483-484.
37. Feng, B., and Tabas, I. 2002. ABCA1-mediated cholesterol efflux is defective in free cholesterol-loaded macrophages. Mechanism involves enhanced ABCA1 degradation in a process requiring full NPC1 activity. J. Biol. Chem. 277:43271-43280.
38. Yao, P.M., and Tabas, I. 2000. Free cholesterol loading of macrophages induces apoptosis involving the fas pathway. J. Biol. Chem. 275:23807-23813.
39. Haghpassand, M., Bourassa, P.A., Francone, O.L., and Aiello, R.J. 2001. Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. J. Clin. Invest. 108:1315-1320. doi: 10.1172/JCI200112810.
40. Joseph, S.B., et al. 2002. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc. Natl. Acad. Sci. USA. 99:7604-7609.
41. Repa, J.I., et al. 2000. Regulation of mouse sterol regulatory elementbinding protein-1 c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev. 14:2819-2830.
42. Schultz, J.R., et al. 2000. Role of LXRs in control of lipogenesis. Genes Dev. 14:2831-2838.
43. Srracher, A. 1999. Calpain inhibitors as therapeutic agents in nerve and muscle degeneration. Ann. NY Acad. Sci. 884:52-59.